Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain

Table 1 Unit costs of resources utilized

Health and non-health resources	2011 Unit costs (€)
Medical visits
Primary care	23.19
Emergency room	117.53
Specialist	104.41
Complementary tests*
Laboratory tests^†	22.30
Conventional radiology^‡	18.50
Diagnostic/therapeutic tests*	37.12
Drug prescription^§	Retail^‖
Hospitalization (one day in a general ward)	320.90

Information sources: study site cost accounting and Spanish National Institute of Statistics.
*Includes ultrasound scans or other diagnostic imaging tests and electrocardiograms.
^†Includes blood count, biochemistry, lipid panel, urinalysis, thyroid function.
^‡ Includes X-ray measurements.
^§ Includes the costs of antimuscarinic drugs, absorbent products and concomitant medications (antidepressants, anxiolytics, antibiotics, anti-infective drugs, laxatives and dermatologic products for skin infections).
^‖Retail: retail price + value added tax (for year 2011).

ISSN: 1471-2490